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ing perfusion should be undertaken, before or after
revascularisation, or occasionally as an attempt to
avoid surgery in a high-risk patient with marginal via-
bility. These include: keeping the foot dependent,
avoiding extrinsic pressure over the heel or bony
prominence, avoiding temperature extremes (cold
induces vasoconstriction, whereas heat raises the
metabolic rate and circulatory demand), maximising
tissue oxygenation, and correcting hypotension. Used
in combination with measures to maximise cardiac
function, these may produce gratifying results.
In summary, although the ischaemic limb is the nat-
ural focus of attention, the prime consideration should
be life rather than limb. The mentioned supportive
measures should be an integral part of the overall
management of these patients.
Recommendation 55: Anticoagulant therapy in
acute limb ischaemia
Intravenous heparin at full anticoagulant dosage
should be given as soon as the diagnosis of acute
limb ischaemia has been made, provided that
heparin is not contraindicated and that
spinal/epidural anaesthesia is not planned.
Critical Issue 21: Subcutaneous heparin in acute
limb ischaemia
There is a need to resolve whether intravenous
administration of unfractionated heparin before
treatment can be replaced with subcutaneous
un fractionated or low-molecular-weight heparin in
the setting of acute limb ischaemia.
Recommendation 56: Vasoactive drugs or sympa-
thectomy in acute limb ischaemia
There is no evidence that "vasoactive" drugs or
sympathectomy are of benefit in the treatment of
acute limb ischaemia.
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C 4.2
Endovascular Procedures for Acute Limb
Ischaemia
C 4.2.1
Thrombolysis
Formal angiography is performed only in patients
in whom the degree of severity allows time (ie,
severity levels I and l1a). In many such patients,
depending on other factors (see Recommendation
57), angiographic findings, catheter-directed throm-
bolytic therapy is the initial treatment chosen. The
choice depends on location and anatomy of lesions,
duration of the occlusion, the type of clot (embolus
vs thrombosis), patient risk (comorbidities), and
risk of procedure (eg, embolectomy under local vs
arterial bypass under general anaesthesia).
Contraindications to thrombolysis must obviously
be observed. However, as a gentler method of clot
removal that potentially may avoid or reduce the
scope of open surgery, catheter-directed thromboly-
sis is often the initial treatment chosen in levels I
and -l1a patients. In such instances, the next step
after performing angiography for acute occlusion is
to pass a guidewire through the occluded artery. If
the guidewire passes, then intrathrombus lysis
should be initiated. If the catheter fails to pass,
regional infusion with the catheter placed proximal-
ly may be considered in an effort to facilitate one
subsequent attempt at catheterising the thrombosed
segment. Regional infusion should not exceed 6
hours before attempting to achieve the optimal
catheter position. Any clinical deterioration during
regional infusion should signal the need to discon-
tinue thrombolysis and proceed with surgical revas-
cularisation.
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Recommendation 57: Factors for consideration in
choosing intervention for acute limb ischaemia
The choice as to which intervention should be used
for acute limb ischaemia should be based on
• location and anatomy of lesion
• duration of acute limb ischaemia
• type of clot
• patient-related risks
• surgery-related risks
• contraindications to thrombolysis
Recommendation 58: Thrombolysis after arterio-
graphy in acute limb ischaemia
If the decision is made to proceed with thromboly-
sis after arteriography, then the intrathrombus infu-
sion method should be used, which can be per-
formed successfully in most cases.
Catheter-directed thrombolysis has the theoretical
and practical advantages over thromboembolectomy
of decreasing endothelial trauma and, in conjunction
with angiographic control, uncovering the underlying
lesion(s) and visualising the runoff vessels.' Its superi-
ority over intravenously administered thrombolytic
agents is well established, and the latter should not be
used in ALI. It has been suggested that gradual, low-
pressure repcrfusion may be advantageous in prefer-
ence to the sudden, high-pressure reperfusion associ-
ated with surgical revascularisationP
Recommendation 59: High-dose systemic throm-
bolysis in arterial occlusion
Intravenous administration of high doses of cur-
rently available thrombolytic agents should no
longer be used for the treatment of arterial occlu-
sion in the leg.
Table 34. Contraindications to thrombolysis'
With intraarterial streptokinase, tissue plasminogen
activator or urokinase, successful recanalisation is
possible in most carefully selected patients.
Furthermore, after successful thrombolysis in athero-
sclerotic arteries, the underlying lesion should usually
be identified. It then should be corrected by the most
appropriate percutaneous or open surgical technique
if long-term patency is to be achleved.v'
C 4.2.2
Contraindications to Thrombolysis (Table 34)
C4.2.3
Other Endovascular Techniques
When thrombolysis indicates underlying localised
disease (eg, a discrete, short stenosis), catheter-based
revascularisation such as percutaneous transluminal
angioplasty (PTA) becomes an attractive option.
Stenoses and occlusions are rarely the sole cause of
ALI or even severe chronic symptoms but commonly
lead to superimposed thrombosis and therefore
should be treated to avoid recurrent thrombosiss» (see
C 4.6, Treatment of the Underlying Lesion, p 5136).
Until recently, catheter-directed thrombolysis and
open surgical thrombectomy were the only two basic
options for dealing with arterial thromboembolism.
Percutaneous aspiration thrombectomy (PAT) and
percutaneous mechanical thrombectomy (PMT) pro-
vide an alternative nonsurgical modality for the treat-
ment of acute limb ischaemia.
In high-risk patients, in whom any form of surgery
is highly dangerous, it has been suggested that one of
the newer techniques of thrombolysis, such as PMT or
PAT, may be safer than emergency surgery;"
Absolutecontraindications
1. Established cerebrovascular event (excluding TIA within previous 2 months)
2. Active bleeding diathesis
3. Recent gastrointestinal bleeding (within previous 10 days)
4. Neurosurgery (intracranial, spinal) within previous 3 months
5. Intracranial trauma within previous 3 months
Relative coniraindications
1. Ca:diopulmonary resuscitation within previous 10 days
2. Major nonvascular surgery or trauma within previous 10 days
3. Uncontrolled hypertension (systolic >180 mm Hg or diastolic >110 mm Hg)
4. Puncture of noncompressible vessel
5. Intracranial tumour
6. Recent eye surgery
Minor contraindications
1. Hepatic failure, particularly those with coagulopathy
2. Bacterial endocarditis
3. Pregnancy
4. Diabetic haemorrhagic retinopathy
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Percutaneous aspiration thrombectomy (PAT)
PAT is a technique that uses thin-wall, large-lumen
catheters and suction with a 50-mL syringe to remove
embolus or thrombus from native femoropopliteal
arteries, bypass grafts, and run-off vessels. It has been
used together with fibrinolysis to reduce time and
dose of the fibrinolytic agent or as a stand-alone pro-
cedure.8•9, l0
Percutaneous mechanical thrombectomy (PMT)
Most PMT devices operate on the basis of hydro-
dynamic recirculation. According to this concept, dis-
solution of the thrombus occurs within an area of con-
tinuous mixing referred to as the "hydrodynamic vor-
tex." This selectively traps, dissolves, and evacuates
the thrombus. Non-recirculation devices, which func-
tion primarily by direct mechanical thrombus frag-
mentation, have been used less frequently for periph-
eral arterial disease because of the higher risk of
peripheral embolisation and higher potential for vas-
cular injury,'! Results from representative studies
using rotational" and hydraulic recirculation devices
13,1~ are listed in Table 35.
The patients entered into these three studies were
not identical. For instance, most patients in the study
by Reekers et al13 had acute graft occlusion, and the
duration of the occlusion was also longer than in the
study by Rilinger et al.12 Most of the patients in the
Rilinger et al12 and Wagner et al l4 studies had occlu-
sions caused by emboli. Nevertheless, the results were
surprisingly similar. In Rilinger et al's study,'> most
patients did not need any additional procedures. By
contrast, in the other two studies, approximately 90%
of patients required adjunctive catheter treatments
such as angioplasty, local intraarterial thrombolysis, or
atherectomy.w-
The efficiency of PMT depends mainly on the age
of the thrombus; fresh thrombus responds better than
older material. Embolic material is not treated with a
hydraulic device. Fragmentation devices show better
results in embolic occlusions. The limited available
clinical experience suggests that PAT or PMT may be
used effectively.II,12.13.l4 They may be used more safe-
ly to replace time-consuming and typically more
expensive pharmacological thrombolysis. Trials com-
paring PAT or PMT with standard catheter-directed
thrombolysis or surgical thromboembolectomy are
needed to establish their therapeutic role (Critical
Issue 22, p 5135).
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Table 35: Patency, limb salvage, and mortality after percutaneous mechanical thrombectomy
Rilinger ct alp 1997
Reekers et alp 1996
Wagner et al,H 1997
Amplatz
Hydrolyser
Angiojet
n
40
28
50
Patency ('Yo)
Postopera tive
95
93
90
Limb salvage (%) Mortality (%)
30 days 30 days 30 days
95 0
50 89 4
76 94 0
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